A theme focused on jointly developing a treatment for cleft lip and palate (alveolar cleft) by combining Cell Technology's dental pulp stem cells with ORTHOREBIRTH's synthetic bone graft material. It also includes research into related diseases under agreements with universities, research institutions and Mochida Pharmaceutical.